— Know what they know.
Not Investment Advice
Also trades as: SNN.CN (CNQ) · $vol 0M

SNNVF OTC

Sunniva Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +900.0% 1Y: +900.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 50 · $3921 mcap · 39M float · 0.0007% daily turnover

Income Trends

Revenue
$19M +16.9% ▲
Gross Profit
$8M +16.7% ▲
Operating Income
-$28M -97.9% ▼
Net Income
-$29M -57.3% ▼
EPS (Diluted)
$-0.91 -51.7% ▼
EBITDA
-$25M -51.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2015FY2016FY2017FY2018
Revenue$0$38K$16M$19M
YoY Growth+0.0%+0.0%+42194.7%+16.9%
Cost of Revenue$0$12K$9M$11M
Gross Profit$0$26K$7M$8M
Gross Margin—68.4%41.6%41.5%
R&D Expenses$513K$314K$110K$0
SG&A Expenses$1M$4M$18M$33M
Operating Expenses$2M$4M$21M$36M
Operating Income-$2M-$6M-$14M-$28M
Operating Margin—-15876.3%-88.4%-149.7%
Interest Expense$1K$885K$313K$2M
Income Before Tax-$2M-$7M-$20M-$29M
Tax Expense$0$0-$2M-$308K
Net Income-$2M-$7M-$18M-$29M
Net Margin—-18123.7%-114.9%-154.6%
EPS (Diluted)$-0.06$-0.22$-0.60$-0.91
EBITDA-$2M-$5M-$17M-$25M
Shares Outstanding31M31M31M32M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms